Hippo Signaling in the Liver Regulates Organ Size, Cell Fate, and Carcinogenesis.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 28003097.
- Also identified by DOI 10.1053/j.gastro.2016.10.047 and PMC identifier 5285449.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The Hippo signaling pathway, also known as the Salvador-Warts-Hippo pathway, is a regulator of organ size. The pathway takes its name from the Drosophila protein kinase, Hippo (STK4/MST1 and STK3/MST2 in mammals), which, when inactivated, leads to considerable tissue overgrowth. In mammals, MST1 and MST2 negatively regulate the transcriptional co-activators yes-associated protein 1 and WW domain containing transcription regulator 1 (WWTR1/TAZ), which together regulate expression of genes that control proliferation, survival, and differentiation. Yes-associated protein 1 and TAZ activation have been associated with liver development, regeneration, and tumorigenesis. How their activity is dynamically regulated in these contexts is just beginning to be elucidated. We review the mechanisms of Hippo signaling in the liver and explore outstanding questions for future research.
Medical subject headings
- Adaptor Proteins, Signal Transducing
- Carcinoma, Hepatocellular
- Intracellular Signaling Peptides and Proteins
- Liver
- Liver Neoplasms
- Phosphoproteins
- Protein Serine-Threonine Kinases
- Transcription Factors